{"id":"W3209530143","doi":"10.1182/blood-2021-145872","title":"Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Follicular lymphoma; Internal medicine; Salvage therapy; Oncology; Bendamustine; Lymphoma; Rituximab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008290716,0.0005094369,0.000872178,0.0001867306,0.000240762,0.0006016429,0.0003875984,0.0004520374,0.002550019],"category_scores_gemma":[0.0003718256,0.0002313608,0.0005226553,0.0001766922,0.0002956314,0.0004573495,0.0001757184,0.00131369,0.0005028757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004139468,"about_ca_system_score_gemma":0.0004436833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003792451,"about_ca_topic_score_gemma":0.001918385,"domain_scores_codex":[0.9998296,0.00007457674,0.0000129614,0.00002623288,0.00002136908,0.0000352063],"domain_scores_gemma":[0.9997506,0.00004581165,0.0000637359,0.00001718255,0.00001716175,0.0001055471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3802889,0.03291069,0.02888445,0.00142933,0.00180275,0.0006949716,0.0003469556,0.002267567,0.1987788,0.0003469605,0.01173542,0.3405131],"study_design_scores_gemma":[0.3223727,0.5476102,0.09399668,0.000184203,0.001578702,0.00153368,0.0002008179,0.003044998,0.01536599,0.0003246331,0.0137195,0.00006792763],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923646,0.003545884,0.0003204076,0.000366625,0.00004006701,0.0006302635,0.0005496719,0.00006177499,0.002120603],"genre_scores_gemma":[0.9962132,0.001201458,0.0005129393,0.000350666,0.00005738627,0.0002787338,0.0006859986,0.000008600789,0.000691104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002550019,"threshold_uncertainty_score":0.008530617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01391037133662936,"score_gpt":0.2705252749562076,"score_spread":0.2566149036195782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}